locally manufactured adoptive cellular therapy (ACT) product

BIOLOGICAL2 trials

Sponsors

David Bartlett, MD, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Conditions

Malignant MesotheliomaMalignant Pleural EffusionMetastasis to PleuraPleural Effusion, Malignant

Phase 1

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

RecruitingNCT07192900

David Bartlett, MDMalignant Mesothelioma, Malignant Pleural Effusion, Metastasis to Pleura +1

Start: 2026-03-31End: 2037-12-31Target: 10Updated: 2026-01-15

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Not yet recruitingNCT07443020

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Malignant Mesothelioma, Malignant Pleural Effusion, Metastasis to Pleura +1

Start: 2026-03-01End: 2038-03-01Target: 10Updated: 2026-03-02